$69.44
0[0.00%]
Last update: 4:00PM Get Real Time Here
Scotts Miracle Gro
(NYSE:SMG)Scotts Miracle Gro Stock (NYSE:SMG), Analyst Ratings, Price Targets, Predictions
The Scotts Miracle Gro Co has a consensus price target of $64, established from looking at the 62 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, Truist Securities, and JP Morgan on May 2, 2024, April 5, 2024, and April 5, 2024. With an average price target of $81 between Wells Fargo, Truist Securities, and JP Morgan, there's an implied 17.15% upside for The Scotts Miracle Gro Co from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Truist Securities
JP Morgan
Raymond James
Stifel
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Scotts Miracle Gro
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | Buy Now | 20.05% | Wells Fargo | Chris Carey | $85 → $83 | Maintains | Overweight | Get Alert |
| 04/05/2024 | Buy Now | 8.48% | Truist Securities | Bill Chappell | $65 → $75 | Downgrade | Buy → Hold | Get Alert |
| 04/05/2024 | Buy Now | 22.94% | JP Morgan | Jeffrey Zekauskas | $70 → $85 | Maintains | Overweight | Get Alert |
| 03/25/2024 | Buy Now | — | Raymond James | Joseph Altobello | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 03/04/2024 | Buy Now | -5.99% | Stifel | W. Andrew Carter | $55 → $65 | Maintains | Hold | Get Alert |
| 02/05/2024 | Buy Now | -20.45% | Stifel | W. Andrew Carter | $49 → $45 | Maintains | Hold | Get Alert |
| 10/30/2023 | Buy Now | -29.13% | Stifel | W. Andrew Carter | $55 → $49 | Maintains | Hold | Get Alert |
| 09/05/2023 | Buy Now | -13.22% | Barclays | Gaurav Jain | $70 → $60 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | Buy Now | -20.45% | Stifel | W. Andrew Carter | $68 → $55 | Maintains | Hold | Get Alert |
| 08/03/2023 | Buy Now | 1.24% | Raymond James | Joseph Altobello | $86 → $70 | Maintains | Strong Buy | Get Alert |
| 08/03/2023 | Buy Now | 8.48% | Truist Securities | Bill Chappell | $80 → $75 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | -1.65% | Stifel | W. Andrew Carter | $72 → $68 | Maintains | Hold | Get Alert |
| 07/13/2023 | Buy Now | 4.14% | Stifel | W. Andrew Carter | $78 → $72 | Downgrade | Buy → Hold | Get Alert |
| 07/11/2023 | Buy Now | — | Truist Securities | Bill Chappell | — | Upgrade | Hold → Buy | Get Alert |
| 05/08/2023 | Buy Now | 15.71% | JP Morgan | Jeffrey Zekauskas | → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 05/04/2023 | Buy Now | -5.99% | Truist Securities | Bill Chappell | $70 → $65 | Maintains | Hold | Get Alert |
| 05/04/2023 | Buy Now | 22.94% | Wells Fargo | Chris Carey | $100 → $85 | Maintains | Overweight | Get Alert |
| 05/01/2023 | Buy Now | 15.71% | Stifel | W. Andrew Carter | $65 → $80 | Upgrade | Hold → Buy | Get Alert |
| 04/26/2023 | Buy Now | 1.24% | Barclays | Gaurav Jain | $105 → $70 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/06/2023 | Buy Now | 15.71% | UBS | Peter Grom | $87 → $80 | Maintains | Neutral | Get Alert |
| 02/21/2023 | Buy Now | 51.87% | Barclays | Gaurav Jain | $90 → $105 | Maintains | Overweight | Get Alert |
| 02/16/2023 | Buy Now | 44.63% | Wells Fargo | Chris Carey | $75 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/02/2023 | Buy Now | 1.24% | Truist Securities | Bill Chappell | $50 → $70 | Maintains | Hold | Get Alert |
| 02/02/2023 | Buy Now | 15.71% | JP Morgan | Jeffrey Zekauskas | $45 → $80 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | 8.48% | Wells Fargo | Chris Carey | $60 → $75 | Maintains | Equal-Weight | Get Alert |
| 02/02/2023 | Buy Now | 33.06% | Raymond James | Joseph Altobello | $56 → $92 | Maintains | Strong Buy | Get Alert |
| 01/31/2023 | Buy Now | -13.22% | Wells Fargo | Chris Carey | $50 → $60 | Maintains | Equal-Weight | Get Alert |
| 01/31/2023 | Buy Now | 30.17% | Barclays | Gaurav Jain | $75 → $90 | Maintains | Overweight | Get Alert |
| 11/08/2022 | Buy Now | 8.48% | Barclays | Gaurav Jain | → $75 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/03/2022 | Buy Now | -34.91% | JP Morgan | Jeffrey Zekauskas | $80 → $45 | Maintains | Neutral | Get Alert |
| 11/03/2022 | Buy Now | -19% | Raymond James | Joseph Altobello | $100 → $56 | Maintains | Strong Buy | Get Alert |
| 10/03/2022 | Buy Now | -27.68% | Wells Fargo | Chris Carey | $75 → $50 | Maintains | Equal-Weight | Get Alert |
| 09/01/2022 | Buy Now | 8.48% | Wells Fargo | Chris Carey | $85 → $75 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | Buy Now | 24.39% | UBS | Peter Grom | $92 → $86 | Maintains | Neutral | Get Alert |
| 08/04/2022 | Buy Now | 44.63% | Raymond James | Joseph Altobello | $110 → $100 | Maintains | Strong Buy | Get Alert |
| 07/22/2022 | Buy Now | 33.06% | UBS | Peter Grom | $125 → $92 | Downgrade | Buy → Neutral | Get Alert |
| 06/22/2022 | Buy Now | 22.94% | Wells Fargo | Chris Carey | → $85 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/14/2022 | Buy Now | 34.51% | Stifel | W. Andrew Carter | $116 → $93 | Maintains | Hold | Get Alert |
| 06/09/2022 | Buy Now | 66.33% | Wells Fargo | Chris Carey | $130 → $115 | Maintains | Overweight | Get Alert |
| 06/09/2022 | Buy Now | 37.4% | JP Morgan | Jeffrey Zekauskas | → $95 | Downgrade | Overweight → Neutral | Get Alert |
| 06/09/2022 | Buy Now | 59.1% | Raymond James | Joseph Altobello | $125 → $110 | Maintains | Strong Buy | Get Alert |
| 06/08/2022 | Buy Now | 22.94% | Truist Securities | Bill Chappell | $185 → $85 | Downgrade | Buy → Hold | Get Alert |
| 06/02/2022 | Buy Now | 88.02% | Wells Fargo | Chris Carey | $145 → $130 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | 80.79% | Raymond James | Joseph Altobello | $150 → $125 | Maintains | Strong Buy | Get Alert |
| 05/04/2022 | Buy Now | 109.72% | Wells Fargo | Chris Carey | $155 → $145 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | 88.02% | JP Morgan | Jeffrey Zekauskas | → $130 | Upgrade | Neutral → Overweight | Get Alert |
| 05/04/2022 | Buy Now | 67.78% | Stifel | W. Andrew Carter | $130 → $116 | Downgrade | Buy → Hold | Get Alert |
| 04/21/2022 | Buy Now | 59.1% | Barclays | Gaurav Jain | $150 → $110 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/17/2022 | Buy Now | 131.41% | Wells Fargo | Chris Carey | $170 → $160 | Maintains | Overweight | Get Alert |
| 03/14/2022 | Buy Now | 116.95% | Raymond James | Joseph Altobello | $185 → $150 | Maintains | Strong Buy | Get Alert |
| 02/03/2022 | Buy Now | 167.57% | Raymond James | Joseph Altobello | $195 → $185 | Maintains | Strong Buy | Get Alert |
| 01/05/2022 | Buy Now | 182.04% | Raymond James | Joseph Altobello | $200 → $195 | Maintains | Strong Buy | Get Alert |
| 12/07/2021 | Buy Now | 160.34% | Wells Fargo | Chris Carey | — | Initiates | → Overweight | Get Alert |
| 11/18/2021 | Buy Now | 196.5% | Barclays | Gaurav Jain | — | Initiates | → Overweight | Get Alert |
| 09/28/2021 | Buy Now | 225.43% | Truist Securities | Bill Chappell | — | Maintains | Buy | Get Alert |
| 09/15/2021 | Buy Now | 189.27% | Raymond James | Joseph Altobello | — | Maintains | Strong Buy | Get Alert |
| 08/05/2021 | Buy Now | 232.66% | Raymond James | Joseph Altobello | — | Maintains | Strong Buy | Get Alert |
| 07/28/2021 | Buy Now | 218.19% | Stifel | W. Andrew Carter | — | Initiates | → Buy | Get Alert |
| 07/12/2021 | Buy Now | 261.59% | Truist Securities | Bill Chappell | — | Maintains | Buy | Get Alert |
| 06/24/2021 | Buy Now | 225.43% | UBS | Peter Grom | — | Initiates | → Buy | Get Alert |
| 06/23/2021 | Buy Now | 261.59% | Raymond James | Joseph Altobello | — | Maintains | Strong Buy | Get Alert |
| 06/02/2021 | Buy Now | 341.13% | Raymond James | Joseph Altobello | — | Maintains | Strong Buy | Get Alert |
FAQ
What is the target price for Scotts Miracle Gro (SMG)?
The latest price target for Scotts Miracle Gro (NYSE: SMG) was reported by Wells Fargo on May 2, 2024. The analyst firm set a price target for $83.00 expecting SMG to rise to within 12 months (a possible 19.53% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Scotts Miracle Gro (SMG)?
The latest analyst rating for Scotts Miracle Gro (NYSE: SMG) was provided by Wells Fargo, and Scotts Miracle Gro maintained their overweight rating.
When was the last upgrade for Scotts Miracle Gro (SMG)?
The last upgrade for The Scotts Miracle Gro Co happened on July 11, 2023 when Truist Securities raised their price target to N/A. Truist Securities previously had a hold for The Scotts Miracle Gro Co.
When was the last downgrade for Scotts Miracle Gro (SMG)?
The last downgrade for The Scotts Miracle Gro Co happened on April 5, 2024 when Truist Securities changed their price target from $65 to $75 for The Scotts Miracle Gro Co.
When is the next analyst rating going to be posted or updated for Scotts Miracle Gro (SMG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Scotts Miracle Gro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Scotts Miracle Gro was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
Is the Analyst Rating Scotts Miracle Gro (SMG) correct?
While ratings are subjective and will change, the latest Scotts Miracle Gro (SMG) rating was a maintained with a price target of $85.00 to $83.00. The current price Scotts Miracle Gro (SMG) is trading at is $69.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.